Skip to main content
. Author manuscript; available in PMC: 2021 Mar 1.
Published in final edited form as: J Hepatol. 2019 Oct 10;72(3):391–400. doi: 10.1016/j.jhep.2019.09.029

Fig. 6. Presence of Candidalysin associates with disease severity and mortality in patients with alcoholic hepatitis.

Fig. 6.

(A) MELD score for patients with alcoholic hepatitis. (Candidalysin positive, n=27; Candidalysin negative, n=62). (B) Kaplan-Meier curve of 90-day mortality for patients with alcoholic hepatitis. (Candidalysin positive, n=25; Candidalysin negative, n=61). Patients were grouped according to their ECE1 status in stool. Patients lost to follow-up were censored at the time they were last seen alive. Results are expressed as median with range. P value was determined by Mann-Whitney-Wilcoxon test (A) or Log-rank test (B).

HHS Vulnerability Disclosure